Letter: surgery for ulcerative colitis mostly follows anti-TNF drugs - a new 'therapeutic package'?

被引：1

作者：

Barreiro-de Acosta, M. ^{[1
]}

Gisbert, J. P. ^{[1
]}

机构：

[1] Hosp Clinico Univ Santiago Compostela, Dept Gastroenterol, Santiago, Spain

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2012年 / 36卷 / 03期

关键词：

POSTOPERATIVE COMPLICATIONS; INFLIXIMAB; MANAGEMENT; RISK;

D O I：

10.1111/j.1365-2036.2012.05158.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：297 / 298

页数：2

共 10 条

[1] Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study
Barreiro-de Acosta, M.
Garcia-Bosch, O.
Souto, R.
Manosa, M.
Miranda, J.
Garcia-Sanchez, V.
Gordillo, J.
Chacon, S.
Loras, C.
Carpio, D.
Maroto, N.
Menchen, L.
Rojas-Feria, M.
Sierra, M.
Villoria, A.
Marin-Jimenez, I.
[J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (05) : 812 - 817
[2] Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis
Barreiro-de Acosta, Manuel
Lorenzo, Aurelio
Mera, Jose
Enrique Dominguez-Munoz, J.
[J]. JOURNAL OF CROHNS & COLITIS, 2009, 3 (04) : 271 - 276
[3] Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study
Chaparro, M.
Burgueno, P.
Iglesias, E.
Panes, J.
Munoz, F.
Bastida, G.
Castro, L.
Jimenez, C.
Mendoza, J. L.
Barreiro-de Acosta, M.
Gomez Senent, S.
Gomollon, F.
Calvet, X.
Garcia-Planella, E.
Gomez, M.
Hernandez, V.
Hinojosa, J.
Manosa, M.
Perez Nyssen, O.
Gisbert, J. P.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) : 275 - 283
[4] Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study
Järnerot, G
Hertervig, E
Friis-Liby, I
Blomquist, L
Karlé, P
Grännö, C
Vilien, M
Ström, M
Danielsson, Å
Verbaan, H
Hellström, PM
Magnuson, A
Curman, B
[J]. GASTROENTEROLOGY, 2005, 128 (07) : 1805 - 1811
[5] Review article: restorative proctocolectomy, indications, management of complications and follow-up - a guide for gastroenterologists
McLaughlin, S. D.
Clark, S. K.
Tekkis, P. P.
Ciclitira, P. J.
Nicholls, R. J.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (10) : 895 - 909
[6] Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy
Mor, I. J.
Vogel, J. D.
Moreira, A. da Luz
Shen, B.
Hammel, J.
Remzi, F. H.
[J]. DISEASES OF THE COLON & RECTUM, 2008, 51 (08) : 1202 - 1207
[7] Pre-operative use of anti-TNF-a agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study
Norgard, B. M.
Nielsen, J.
Qvist, N.
Gradel, K. O.
de Muckadell, O. B. S.
Kjeldsen, J.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (11) : 1301 - 1309
[8] Infliximab for induction and maintenance therapy for ulcerative colitis
Rutgeerts, P
Sandborn, WJ
Feagan, BG
Reinisch, W
Olson, A
Johanns, J
Travers, S
Rachmilewitz, D
Hanauer, SB
Lichtenstein, GR
de Villiers, WJS
Present, D
Sands, BE
Colombel, JF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) : 2462 - 2476
[9] Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis
Selvasekar, Chelliah R.
Cima, Robert R.
Larson, David W.
Dozois, Eric J.
Harrington, Jeffrey R.
Harmsen, William S.
Loftus, Edward V., Jr.
Sandborn, William J.
Wolff, Bruce G.
Pemberton, John H.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 204 (05) : 956 - 962
[10] European evidence-based Consensus on the management of ulcerative colitis: Current management
Travis, S. P. L.
Stange, E. F.
Lemann, M.
Oresland, T.
Bemelman, W. A.
Chowers, Y.
Colombel, J. F.
D'Haens, G.
Ghosh, S.
Marteau, P.
Kruis, W.
Mortensen, N. J. Mcc.
Penninckx, F.
Gassull, M.
[J]. JOURNAL OF CROHNS & COLITIS, 2008, 2 (01) : 24 - 62

← 1 →